Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application...

|About: Teva Pharmaceutical Industr... (TEVA)|By:, SA News Editor

Teva Pharmaceutical (TEVA +0.3%) says the FDA has approved its Abbreviated New Drug Application for the generic version of Shire's (SHPG) Adderall XR capsules for the treatment of ADD. Adderall XR had annual sales, including brand and generic sales, of approximately $2B in the U.S. last year.